Columnist Dagmar Munn says her ALS diagnosis unexpectedly changed her mental clock. Every second of life became significant, she says.
A trial in Italy that's testing Avextra’s cannabis-based medicine for ALS and other neurodegenerative diseases enrolled its ...
People with ALS in the U.S. spend over $47,000 for medical care in the year after diagnosis, more than 3.5 times the average ...
Researchers developed a cell-free DNA blood test that accurately distinguishes ALS from other neurological diseases and tracks progression.
A new dashboard by the ALS Association offers free and open access to real-world data from more than 4,000 people affected by ...
Living with ALS has taken a toll, but columnist Kristin Neva feels like she is doing better now than she has in a long time.
Researchers have identified new blood and spinal fluid biomarkers that could help track ALS progression and monitor treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback